HIGHLIGHTS
- who: Jianjun Qi and collaborators from the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Fannin Street have published the paper: Aptamer-Gemcitabine Conjugates with Enzymatically Cleavable Linker for Targeted Delivery and Intracellular Drug Release in Cancer Cells, in the Journal: Pharmaceuticals 2022, 15, x FOR PEER REVIEW of 13/04/2022
- what: The study demonstrates a novel approach to aptamer-mediated targeted drug delivery that combines a high drug payload and an enzymatically controlled drug release switch to achieve higher therapeutic efficacy and fewer off-target effects relative to free-drug chemotherapy. The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.